Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment
Background: Unfractionated heparin is commonly used for anticoagulation in extracorporeal membrane oxy-genation (ECMO). Several studies have shown that nafamostat mesilate (NM) has comparable clinical out-comes to unfractionated heparin. This study compared anticoagulation with NM and heparin in a l...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Society for Thoracic and Cardiovascular Surgery
2018-04-01
|
| Series: | Korean Journal of Thoracic and Cardiovascular Surgery |
| Subjects: | |
| Online Access: | https://doi.org/10.5090/kjtcs.2018.51.2.114 |